Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 96 | 2,370 | 1,168 | 1,299 | 529 |
| Depreciation Amortization | 1,068 | 4,258 | 3,207 | 2,163 | 1,088 |
| Income taxes - deferred | -431 | -731 | -628 | -321 | -104 |
| Accounts receivable | -103 | 1,154 | 1,841 | 211 | -682 |
| Accounts payable and accrued liabilities | -153 | -905 | -1,196 | -657 | -442 |
| Other Working Capital | -617 | 256 | 600 | -382 | -602 |
| Other Operating Activity | 716 | 1,660 | 1,664 | 1,840 | 1,818 |
| Operating Cash Flow | $576 | $8,062 | $6,656 | $4,153 | $1,605 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -354 | -1,736 | -1,115 | -607 | -294 |
| Net Acquisitions | N/A | -2,878 | -2,863 | -2,863 | -2,378 |
| Other Investing Activity | 0 | -62 | 0 | 0 | 0 |
| Investing Cash Flow | $-354 | $-4,676 | $-3,978 | $-3,470 | $-2,672 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,049 | 500 | 500 | 500 | 500 |
| Debt Repayment | N/A | -3,850 | -1,500 | -701 | N/A |
| Common Stock Issued | 1,553 | 2,287 | 461 | 402 | 267 |
| Financing Cash Flow | $3,602 | $-1,063 | $-539 | $201 | $767 |
| Exchange Rate Effect | -756 | 442 | 230 | -145 | 248 |
| Beginning Cash Position | 20,681 | 17,916 | 17,916 | 17,916 | 17,916 |
| End Cash Position | 23,749 | 20,681 | 20,285 | 18,655 | 17,864 |
| Net Cash Flow | $3,068 | $2,765 | $2,369 | $739 | $-52 |
| Free Cash Flow | |||||
| Operating Cash Flow | 576 | 8,062 | 6,656 | 4,153 | 1,605 |
| Capital Expenditure | -354 | -1,769 | -1,151 | -610 | -297 |
| Free Cash Flow | 222 | 6,293 | 5,505 | 3,543 | 1,308 |